Amanote Research
Register
Sign In
Peg-Interferon /Ribavirin With and Without Rituximab for Hepatitis C-Related Mixed Cryoglobulinemia
Blood
- United States
doi 10.1182/blood-2010-06-293787
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Immunology
Cell Biology
Hematology
Date
July 22, 2010
Authors
Unknown
Publisher
American Society of Hematology
Related search
Hepatitis C Eradication and Improvement of Cryoglobulinemia-Associated Rash and Membranoproliferative Glomerulonephritis With Interferon and Ribavirin After Kidney Transplantation
Canadian Journal of Gastroenterology
Thyroid Hormonal Disturbances Related to Treatment of Hepatitis C With Interferon-Alpha and Ribavirin
Clinics
Medicine
Hepatitis C Virus Infection and Cutaneous Vasculitis in Mixed Cryoglobulinemia
Mayo Clinic Proceedings
Medicine
Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction
Acta Hepatologica Japonica
Hepatology
Mixed Treatment Comparisons to Compare Simeprevir With Boceprevir and Telaprevir in Combination With Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected With Genotype 1 Hepatitis C Virus (Hcv)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia
Current Therapeutic Research
Pharmacology
Sofosbuvir Plus Daclatasvir With or Without Ribavirin in 551 Patients With Hepatitis C-Related Cirrhosis, Genotype 4
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Cost Effectiveness of Interferon or Peginterferon With Ribavirin for Histologically Mild Chronic Hepatitis C
Gut
Gastroenterology
The Course of Inactive Hepatitis B in Hepatitis-C-Coinfected Patients Treated With Interferon and Ribavirin
Antiviral Therapy
Infectious Diseases
Pharmacology
